Our CEO Henk Johan Streefkerk is looking forward to meet you at Sachs European Life Sciences CEO Forum (ELSF)
Nov 06 - Nov 08, 2023
Amarna Therapeutics will be present at Europe's flagship partnering event, Bio-Europe 2023. Happy to meet you there.
Oct 17 - Oct 18, 2023
Join us at Bio Investor Forum 2023. Our CEO Henk Streefkerk will be happy to meet you there!
Oct 04 - Oct 05, 2023
Meet us at World Drug Safety Congress Europe 2023 where our CEO Henk Streefkerk will present our lead programs on hemophilia B and type 1 diabetes mellitus on October 5!
Oct 02 - Oct 04, 2023
We look forward meeting you at BioCentury-BayHelix East-West Summit 2023!
Sep 20 - Sep 21, 2023
See you at the 23rd Annual Biotech in Europe Forum where our CEO Henk Johan Streefkerk will present our program on hemophilia B and type 1 diabetes mellitus on September 20!
Sep 19, 2023
Meet us at 10th Annual HealthTech Investment Forum, which is a part of the exciting Sachs Autumn Life Sciences Week
Sep 18, 2023
Join us at RESI conference. Our CEO Henk Johan Streefkerk is happy to meet you there!
Sep 13 - Sep 14, 2023
Our CEO Henk Johan Streefkerk is looking forward meeting you at LSX Congress USA; a dynamic conference on partnering, strategy and investment
Jun 05 - Jun 08, 2023
Join us at Bio International Convention 2023. We look forward to meeting you!
May 14 - May 16, 2023
Meet us at BioEquity 2023, where Amarna Therapeutics will be one of the presenting companies.
May 02 - May 04, 2023
Looking forward to the Gene Therapy Analytical Development Europe Summit, where Jeroen van der Velden presents the development of potency assays for the new SV40 vector gene delivery platform technology!
Mar 20 - Mar 22, 2023
We like to see you at Bio Europe Spring 2023; Europe's largest partnering conference.
Jan 09 - Jan 12, 2023
Amarna Therapeutics is present at the 41st Annual J.P. Morgan Health Care Conference
Nov 24, 2022
Join us at the 'Dutch Life Sciences Conference', where Peter de Haan (CSO) will talk about how Amarna Therapeutics is unlocking the potential and expanding the boundaries of gene therapy by rendering our worst enemies into our closest friends
Oct 26 - Oct 27, 2022
At the end of October, Thijs Gerritzen will present Amarna’s SVec platform at the Gene Therapy for Rare Disorders Europe Summit
Oct 24 - Oct 26, 2022
Amarna Therapeutics will participate in the Bio Europe Autumn meeting in Leipzig. Looking forward to meet you there
Oct 18 - Oct 20, 2022
Meet Steen Klysner (CEO) and Peter de Haan (CSO) at the 3rd annual Gene Therapy Immunogenicity meeting presenting: Circumventing Immunogenicity in Gene Therapy With SVec, a Novel SV40 Based Viral Vector Platform
Oct 11, 2022
Meet our CEO, Steen Klysner, at the 'Cell and Gene therapy Europe' meeting, facilitating the session: 'Evading the immune response upon in vivo gene therapy with viral vectors'
Oct 10 - Oct 14, 2022
Meet us right now at the 29th ESGT Congress were Peter de Haan (CSO) will present a poster titled 'SVec: A superior platform for next generation gene therapies targeting genetic disorders and autoimmune diseases'.
Oct 04, 2022
Amarna Therapeutics presents two posters on our SVec platform and its production process during the 22nd Netherlands Biotechnology Conference
Jun 13 - Jun 16, 2022
We will be presenting at the Bio International convention in San Diego, looking forward to meeting you there
May 31 - Jun 01, 2022
We will be presenting at the 3rd Annual Gene Therapy and analytical development conference in London, looking forward to meeting you there.
Mar 28 - Mar 31, 2022
We will be present at the digital BioEurope Spring, looking forward to seeing you online..
Nov 04 - Nov 05, 2021
We are pleased to announce that our CSO, Peter de Haan, is a speaker at The 8th Drug Discovery Strategic Summit in Amsterdam
